美国儿科超声造影：儿科放射学会超声造影特别工作组的一项调查
Pediatric contrast-enhanced ultrasound in the United States: a survey by the Contrast-Enhanced Ultrasound Task Force of the Society for Pediatric Radiology.
作者信息
Back Susan J, Maya Carolina, Darge Kassa, Acharya Patricia T, Barnewolt Carol E, Coleman Jamie L, Dillman Jonathan R, Fordham Lynn Ansley, Hwang Misun, Lim Annie, McCarville M Beth, Munden Marthe M, Paltiel Harriet J, Volberg Frank M
机构信息
Department of Radiology, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, 34th Street and Civic Center Boulevard, Philadelphia, PA, 19104, USA.
Department of Radiology, Loma Linda University Children's Hospital, Loma Linda, CA, USA.
出版信息
Pediatr Radiol. 2018 Jun;48(6):852-857. doi: 10.1007/s00247-018-4088-x. Epub 2018 Feb 13.
BACKGROUND
The United States Food and Drug Administration (FDA) recently approved an ultrasound (US) contrast agent for intravenous and intravesical administration in children.
OBJECTIVE
Survey the usage, interest in and barriers for contrast-enhanced US among pediatric radiologists.
MATERIALS AND METHODS
The Contrast-Enhanced Ultrasound Task Force of the Society for Pediatric Radiology (SPR) surveyed the membership of the SPR in January 2017 regarding their current use and opinions about contrast-enhanced US in pediatrics.
RESULTS
The majority (51.1%, 166) of the 325 respondents (26.7% of 1,218) practice in either a university- or academic affiliated group. The most widely used US contrast agent was Lumason® 52.3% (23/44). While lack of expertise and training were reported barriers, all respondents who are not currently using US contrast agents are considering future use.
CONCLUSION
Interest in pediatric contrast US is very high. Education and training are needed to support members who plan to adopt contrast US into practice.
背景
美国食品药品监督管理局（FDA）最近批准了一种超声（US）造影剂，可用于儿童静脉内和膀胱内给药。
目的
调查儿科放射科医生对超声造影增强检查的使用情况、兴趣及障碍。
材料与方法
儿科放射学会（SPR）的超声造影增强检查特别工作组于2017年1月对SPR成员进行了调查，内容涉及他们目前在儿科使用超声造影增强检查的情况及看法。
结果
325名受访者（占1218人的26.7%）中，大多数（51.1%，166人）在大学或学术附属机构工作。使用最广泛的超声造影剂是Lumason®，占52.3%（23/44）。虽然缺乏专业知识和培训被报告为障碍，但所有目前未使用超声造影剂的受访者都在考虑未来使用。
结论
儿科超声造影增强检查的兴趣非常高。需要开展教育和培训，以支持计划在实践中采用超声造影增强检查的成员。
Zotero 插件